Health-care companies rose after more excitement about a new class of weight-loss drugs.
Viking Therapeutics offered investors yet another reason to see it as a long-term challenger to Eli Lilly and Novo Nordisk in obesity drugs, unveiling early-stage data on an experimental obesity pill that hinted at unexpectedly robust efficacy.
Shares of medical device maker Shockwave Medical surged after health-care conglomerate Johnson & Johnson reportedly entered talks to buy it out for about $11 billion.
Sutro Biopharma shares rose after the cancer-focused drug company reported an increase in revenue to $153.7 million in 2023 from $67.8 million a year earlier.
Shares of Equillium fell after the company swung to a loss in the fourth quarter on lower sales.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-26-24 1740ET